Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

PANACEA BIOTEC LTD. - 531349 - Notice Of Extraordinary General Meeting ('EGM') Of The Company And Details Of Cut-Off Date For E-Voting And E-Voting Period

 We would like to inform you that an EGM of the Company is scheduled to be held on Saturday, July 06, 2019 at 11:30 A.M. at the Registered Office of the Company at Ambala-Chandigarh Highway, Lalru - 140501, Punjab. Further, pursuant to the provisions of Section 108 of the Act read with Rule 20 of the Companies (Management and Administration) Rules, 2014, as amended from time to time and Regulation 44 of the SEBI LODR Regulations, 2015, the Company is pleased to provide remote e-voting facility to its members to cast their votes electronically on all resolutions set forth in enclosed Notice. Further, relating to the EGM of the Company, you are requested to take on record the following: 1. For the purpose of exercising remote e-voting facility, the cut-off date shall be Saturday, June 29, 2019. 2. The remote e-voting period shall commence on Wednesday, July 03, 2019 (from 09:00 a.m. IST) and end on Friday, July 05, 2019 (upto 05:00 p.m. IST).
12-06-2019
Bigul

PANACEA BIOTEC LTD. - 531349 - Details Of Shares Dematerialized During May, 2019 Under Regulation 54(5) Of The SEBI (Depositories And Participants) Regulations, 1996

 This is with reference to CDSL's Operating Instructions for Issuers/RTAs, which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, we are enclosing herewith the data of shares dematerialized during the month of May, 2019
07-06-2019
Bigul

Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In continuation to our letter dated May 30, 2019 for approving Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Year ended March 31, 2019 and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of Extract of Statement of aforesaid Audited Financial Results, published in the following newspapers on May 31, 2019:- Business Standard (English); Desh Sewak (Punjabi)
31-05-2019
Bigul

Panacea Biotec Ltd - 531349 - Disclosure Under Regulation 30(2) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 In continuation to our earlier communication dated May 30, 2019 intimating about the outcome of the Board Meeting of the Company held on May 30, 2019, please find enclosed herewith the detailed annexures as required under Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
31-05-2019
Bigul

Annual report for Panacea Biotec Ltd. for FY-2019
31-05-2019
Bigul

PANACEA BIOTEC LTD. - 531349 - Declaration - Auditors' Report On The Annual Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2019 Is With Unmodified Opinion

 In continuation to our letter dated May 30, 2019 intimating the outcome of Board Meeting and pursuant to Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. CIR/CFD/CMD/56/2016 dated May 27, 2016, we would like to confirm that the Auditors' Report on the Annual Audited Financial Results (Standalone and Consolidated) for the Quarter and Year ended March 31, 2019 is with unmodified opinion.
30-05-2019
Bigul

Panacea Biotec Ltd - 531349 - Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended 31.03.2019.

 Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Year ended 31.03.2019.
30-05-2019
Bigul

PANACEA BIOTEC LTD. - 531349 - Outcome of Board Meeting

 Pursuant to Reg 30 of SEBI LODR Regulations, the Board has, at its meeting held today, inter-alia, considered and approved the following:- 1.Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Year ended 31.03.2019. 2.The Scheme of Arrangement for demerger of real estate business of the Company comprising of Radhika Heights Limited alongwith its subsidiaries and two properties, into its wholly owned subsidiary namely, Ravinder Heights Limited, subject to applicable approvals. 3.Subject to the approval of the Shareholders of the Company, amendment in Memorandum and Articles of Association of the Company in alignment with requirements of Companies Act, 2013 and also in accordance with the terms of the Warrant Subscription and Shareholders Agreement and Debenture Trust Deed both dated 06.04.2019 executed by the Company. The meeting of the Board of Directors commenced at 11:30 A.M. and concluded at 5:45 P.M.
30-05-2019
Bigul

Panacea Biotec Ltd - 531349 - Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report29/05/2019 3 Name of the Certifying Firm R&D; Company Secretaries 4 Name of the Certifying Individual Debabrata Deb Nath 5Membership TypeFCS 6 Membership Number 7775 7 CP No. 8612 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO
30-05-2019
Bigul

Panacea Biotec Ltd - 531349 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. Rajesh Jain
24-05-2019
Next Page
Close

Let's Open Free Demat Account